GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IQVIA Holdings Inc (BSP:I1QV34) » Definitions » Cyclically Adjusted Price-to-FCF

IQVIA Holdings (BSP:I1QV34) Cyclically Adjusted Price-to-FCF : 34.98 (As of Jun. 01, 2024)


View and export this data going back to 2020. Start your Free Trial

What is IQVIA Holdings Cyclically Adjusted Price-to-FCF?

As of today (2024-06-01), IQVIA Holdings's current share price is R$298.00. IQVIA Holdings's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was R$8.52. IQVIA Holdings's Cyclically Adjusted Price-to-FCF for today is 34.98.

The historical rank and industry rank for IQVIA Holdings's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

BSP:I1QV34' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 28.25   Med: 38.33   Max: 60.37
Current: 32.12

During the past years, IQVIA Holdings's highest Cyclically Adjusted Price-to-FCF was 60.37. The lowest was 28.25. And the median was 38.33.

BSP:I1QV34's Cyclically Adjusted Price-to-FCF is ranked better than
52.38% of 63 companies
in the Medical Diagnostics & Research industry
Industry Median: 34.51 vs BSP:I1QV34: 32.12

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

IQVIA Holdings's adjusted free cash flow per share data for the three months ended in Mar. 2024 was R$2.547. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is R$8.52 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


IQVIA Holdings Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for IQVIA Holdings's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IQVIA Holdings Cyclically Adjusted Price-to-FCF Chart

IQVIA Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 58.00 35.63 35.85

IQVIA Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.95 36.04 30.90 35.85 37.07

Competitive Comparison of IQVIA Holdings's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, IQVIA Holdings's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IQVIA Holdings's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where IQVIA Holdings's Cyclically Adjusted Price-to-FCF falls into.



IQVIA Holdings Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

IQVIA Holdings's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=298.00/8.52
=34.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IQVIA Holdings's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, IQVIA Holdings's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.547/131.7762*131.7762
=2.547

Current CPI (Mar. 2024) = 131.7762.

IQVIA Holdings Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.207 100.560 0.271
201409 0.515 100.428 0.676
201412 1.191 99.070 1.584
201503 -0.498 99.621 -0.659
201506 0.217 100.684 0.284
201509 2.010 100.392 2.638
201512 1.461 99.792 1.929
201603 0.655 100.470 0.859
201606 0.070 101.688 0.091
201609 1.604 101.861 2.075
201612 1.286 101.863 1.664
201703 -0.073 102.862 -0.094
201706 0.537 103.349 0.685
201709 1.241 104.136 1.570
201712 0.504 104.011 0.639
201803 0.363 105.290 0.454
201806 0.903 106.317 1.119
201809 1.098 106.507 1.359
201812 1.328 105.998 1.651
201903 -0.133 107.251 -0.163
201906 1.134 108.070 1.383
201909 0.937 108.329 1.140
201912 2.324 108.420 2.825
202003 0.137 108.902 0.166
202006 2.242 108.767 2.716
202009 2.888 109.815 3.466
202012 3.780 109.897 4.533
202103 5.190 111.754 6.120
202106 2.541 114.631 2.921
202109 4.609 115.734 5.248
202112 3.683 117.630 4.126
202203 2.129 121.301 2.313
202206 1.109 125.017 1.169
202209 4.831 125.227 5.084
202212 2.706 125.222 2.848
202303 1.747 127.348 1.808
202306 1.573 128.729 1.610
202309 2.909 129.860 2.952
202312 3.771 129.419 3.840
202403 2.547 131.776 2.547

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


IQVIA Holdings  (BSP:I1QV34) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


IQVIA Holdings Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of IQVIA Holdings's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


IQVIA Holdings (BSP:I1QV34) Business Description

Traded in Other Exchanges
Address
2400 Ellis Road, Durham, NC, USA, 27703
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

IQVIA Holdings (BSP:I1QV34) Headlines

No Headlines